March 30, 2022
Nasal congestion is no more common than symptoms for children with asthma despite current reports from the Centers for Disease Control and Prevention, according to a new clinical trial published in the journal Pediatrics.
The researchers found that the quadrivalent live attenuated influenza vaccine (LAIV4), also called the nasal spray vaccine, was as safe for children with asthma as the intramuscular quadrivalent inactivated influenza (IIV4) vaccine, Also known as shooting disease.
The researchers found that in a trial of 151 children between the ages of 5 and 17 with chronic asthma, the vaccine did not increase respiratory problems.
Within 42 days after enrollment, 10.8 percent of children who received nasal medication experienced asthma symptoms, compared with 14.7 percent of those who received the shot.
The nasal spray has been developed as a painless shot for patients between 2 and 49 years of age.
“These data support a review of the management of the use of LAIV4 in children with asthma, which is especially important during chronic kidney disease, in limited periods. IIV4 equipment, at the level of public health clinics / schools that use LAIV, or for children with needle protection., ”The authors wrote.
However, the CDC says it opposes the use of the spray in children with asthma.
The results of the new study are in line with those from a previous study from 2004 showing that spray was associated with an increase in airway problems in children under 3 years of age.